Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats

British Journal of Nutrition

Volumn 94, Issue 6, 2005, Pages 896-901

  Sato, Masao ^a   Shibata, Kenichi ^a   Nomura, Run ^a   Kawamoto, Daisuke ^a   Nagamine, Rika ^a   Imaizumi, Katsumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E deficient mice; Linoleic acid; Monocyte chemoattractant protein 1; Saturated fatty acids

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; MALONALDEHYDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PALM OIL; PROSTAGLANDIN F2 ALPHA; SAFFLOWER OIL; SATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DRUG DOSE REGIMEN; ENDOTHELIUM CELL; FEMALE; FOOD INTAKE; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; URINALYSIS; URINARY EXCRETION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHOLESTEROL; DIETARY FATS; DIETARY SUPPLEMENTS; DINOPROST; ENDOTHELIAL CELLS; FATTY ACIDS; FEMALE; LINOLEIC ACID; LIVER; MALE; MICE; OXIDATIVE STRESS; RNA, MESSENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASOCONSTRICTOR AGENTS;

ANIMALIA; CARTHAMUS TINCTORIUS;

EID: 30744470631     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051409     Document Type: Article

References (36)

1. Anonymous (1977) Report of the American Institute of Nutrition Ad Hoc Committee on Standard for Nutritional Studies. J Nutr 107, 1340-1348.
2. Bonetti PO, Lerman LO & Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23, 168-175.
3. Boring L, Gosling J, Cleary M & Charo IF (1998) Decreased lesion formation in CCR2 -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
4. Bursill CA, Channon KM & Greaves DR (2004) The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Cur Opin Lipidol 15, 145-149.
5. Calleja L, París MA, Paul A, Vilella E, Joven J, Jimênez A, Beltrán G, Uceda M, Maeda N & Osada J (1999) Low-cholesterol and high-fat diets reduces atherosclerotic lesion development in apo E-knockout mice. Arteriol Thromb Vas Biol 19, 2368-2375.
6. Carvajal O, Nakayama M, Kishi T, Sato M, Ikeda I & Imaizumi K (2000) Effect of medium-chain fatty acid positional distribution in dietary triacylglycerol on lymphatic lipid transport and chylomicron composition in rats. Lipids 35, 1345-1351.
7. Chomczynski P & Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
8. George J, Mulkins M, Casey S, Schatzmaan R, Sigal E & Harats D (2000) The effect of n-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atherosclerosis. Atherosclerosis 150, 285-293.
9. Guo J, van Eck M, Twisk J, Maeda N, Benson GM, Groot PHE & van Berkel TJC (2003) Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler Thromb Vasc Biol 23, 447-453.
10. Han KH, Han KO, Green SR & Quehenberger O (1999) Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J Lipid Res 40, 1053-1063.
11. Hennig B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP & McClain CJ (1996) Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr 63, 322-328.
12. Kawahara RS, Deng ZW & Deuel TF (1991) Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J Biol Chem 266, 13261-13266.
13. Krauss RM, Eckel RH, Howard B, et al. (2000) AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102, 2284-2299.
14. Lee YW, Park HJ, Henning B & Toborek M (2001) Linoleic acid induces MCP-1 gene expression in human microvascular endothelial cells through an oxidative mechanism. J Nutr Biochem 12, 648-654.
15. Merkel M, Velez-Carrasco W, Hudgins LC & Breslow JL (2001) Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increases atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci USA 98, 13294-13299.
16. Mertens A & Holvoet P (2001) Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15, 2073-2084.
17. Moreno JJ & Mitjavila MT (2003) The degree of unsaturation of dietary fatty acids and the development of atherosclerosis. J Nutr Biochem 14, 182-195.
18. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE & Roberts LJ (1999) The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metabol Rev 31, 117-139.
19. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA & Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332, 1198-1203.
20. Morrow JD & Roberts LJ (1994) Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 233, 163-174.
21. Napoli C, de Nigris F & Palinski W (2001) Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 82, 674-682.
22. Ni W, Tsuda Y, Sakono M & Imaizumi K (1998) Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr 128, 1884-1889.
23. Ni W, Tsuda Y, Takashima T, Sato H, Sato M & Imaizumi K (2003) Antiatherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br J Nutr 90, 13-20.
24. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D & Witztum JL (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91, 668-676.
25. Rudel LL, Kelley K, Sawyer JK, Shah R & Wilson MD (1998) Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apo B100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol 18, 1818-1827.
26. Rudel LL, Parks JS & Sawyer JK (1995) Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 15, 2101-2110.
27. Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC & Frölich JC (2000) Tandem mass spectrometric quantification of 8-isoprostaglandin F2α and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2α in human urine. J Chromatogr 744B 99-112.
28. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS & Goldstein JL (1996) Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98, 1575-1584.
29. Sokolov BP & Prockop DJ (1994) A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes. Nucleic Acids Res 22, 4009-4015.
30. Tomoyori H, Kawata Y, Higuchi T, Ichi I, Sato H, Sato M, Ikeda I & Imaizumi K (2004) Phytosterol oxidation products are absorbed in the intestinal lymphatics in rats but do not accelerate atherosclerosis in apolipoprotein E-deficient mice. J Nutr 134, 1690-1696.
31. Turpeinen AM, Basu S & Mutanen M (1998) A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot Essent Fatty Acids 59, 229-233.
32. Vogel RA (1999) Cholesterol lowering and endothelial function. Am J Med 107, 479-487.
33. Wahl GM, Stern M & Stark GR (1979) Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 76, 3683-3687.
34. Wübert J, Reder E, Kaser A, Weber PC & Lorenz RL (1997) Simultaneous solid phase extraction, derivatization, and gas chromatographic mass spectrometric quantification of thromboxane and prostacyclin metabolites, prostaglandins, and isoprostanes in urine. Anal Chem 69, 2143-2146.
35. Yagi K (1976) A simple fluorometric assay for lipoprotein in blood plasma. Biochem Med 15, 212-216.
36. Zhao Z, Hjelm NM, Lam CWK & Ho C (2001) One-step solid-phase extraction procedure for F(2)-isoprostanes. Clin Chem 47, 1306-1308.